Pattents wtth prtmary amylotdosts may develop peripheral neuropathy as an early feature Sural nerve biopsy is reported to be a sensittve method for dmgnosmg amyloidosis m such patients. We identified nine pattents, ulttmately diagnosed as having amylotdosts, who were referred for peripheral neuropathy of undetermmed ettology. In six, a sural nerve btopsy demonstrated no amyloid Subsequent examination of other tissue or of the contralateral sural nerve eventually resulted m the correct diagnosis. We conclude that sural nerve biopsy may be less sensittve than previously believed for the dmgnosls of amyloidosis in pattents with peripheral neuropathy secondary to amyloid. When the chnical suspicion of amyloidosls is high, a nondiagnosttc sural nerve biopsy should not dtscourage the performance of further lnvesttgatwe studies
Introduction
Primary amyloidosls is a dxsorder in which the fibrous protein amyloid may be deposited m virtually any tissue (Kyle and Greipp 1983; Cohen 1991) . Smce peripheral neuropathy is frequently an early or presenting feature of amyloidosis (Kyle and Bayrd 1975; Kyle and Greipp 1983; Duston et al. 1989) , the neurologist may be called upon to evaluate patients who are ultimately found to have amyloidosts, but m whom this diagnosis has not yet been established. Previous series (Kelly et al. 1979; Kyle and Greipp 1983; Janssen et al. 1986 ) have indicated a high diagnostic yield from sural nerve biopsy in patients with primary amyloidosls and peripheral neuropathy. We have recently evaluated 9 patients for peripheral neuropathy of unclear etiology who were eventually diagnosed as having amyloidosts.
Correspondence to Zachary Slrnrnons, MD, Dwlslon of Neurology, Pennsylvama State Umversity College of Medicine, Hershey Medical Center, Hershey, PA 17033, USA Tel' (717) Fax (717) In 6 of these patients, Congo red or crystal violet staining of sural nerve biopsy sections as well as electron microscopy failed to show amyloid deposits. This raises questions regarding the sensittvity of routine sural nerve biopsy in the diagnosis of amyloidosis, and emphasizes the need for further diagnostic workup of patients with neuropathy whose clinical presentations and laboratory studies suggest amylotdosis, but in whom routine studies of sural nerve are nondiagnostxc.
Materials and methods
We reviewed records of the Unwersity of Michigan Neuromuscular Clinic and the Geismger Medical Center Department of Neurology for the past 6 years, and identified 9 patients referred for peripheral neuropathy of undetermined etiology who were eventually diagnosed as having amyloldosls. Amyloid was demonstrated m the inittal rectal biopsy in 2 patients and the initial sural nerve biopsy in one. The remaining 6 patients are the subjects of this report None of the patients had systemic cancer, a history of excessive alcohol use, or other dlsorders known to cause neuropathy except for one pattent (patient 3), who had mild diabetes melhtus which was controlled by diet alone. All had undergone comprehensive evaluations to rule out other causes of neuropathy, including physical examinatton, complete blood count, Westergren sedtmentatton rate, ANA, glucose, electrolytes, BUN, creatmine, hver function tests, T4, TSH, vitamin Bt2 level, VDRL or RPR, and chest X-ray. High resolutmn agarose gel serum electrophorests, immunoglobulm quantification, determination of kappa: lambda hght chain ratio, and if necessary immunofixation of serum (Keren et al. 1988) were performed in 5 of the patients, while one underwent serum immunoelectrophorests.
Sural nerve biopsies, taken at the level of the ankle, were divided mto 2 sections tmmediately after surgery The portion for light microscopy was fixed m 10% formalin. One longitudinal and 1-3 cross-sections were then obtained and embedded in paraffin. These blocks were then cut at 2 or more levels. All were stained with hematoxyhn-eosin and with a stain for amylold (crystal violet in patient 4, Congo red in the others). Trichrome staining was also employed in all except patient 6. For 61 all patients, another portion of nerve was fixed in glutaraldehyde and dwided into 2 sections. One section was minced and the pieces embedded in Epon, and the other was processed in glycerol for teasing. At least 10 blocks of epon-embedded material were examined on multiple 1 micron thick tolutdme-stained sections, and one or two of them were selected for electron m~-croscopy All blopstes were reviewed by a neuropathologist (M.B. or J.T.)
Case reports
Two illustrative cases are described.
eattent 2
An 83-year-old man was admitted with a 6-month history of bilateral hand pain and arm weakness He had surgical treatment for bilateral carpal tunnel syndromes 3 years previously and a cholecystectomy for abdominal pare 2 years previously On examination, there was diffuse mdd upper and lower extremity weakness Achilles reflexes were absent Pinprick and vibration were decreased distally Serum protein electrophoresls and lmmunoflxatlon revealed an lgM lambda monoclonal gammopathy Bone marrow biopsy was normal 
Pattent 6
A 68-year-old man presented with a 4-month history ot burning paresthesms of the distal lower extremiUes and fingertips, accompanied by mldllne abdominal numbness. Examination revealed todd weakness of foot dorslflexors and toe extensors Patellar reflexes were depressed, and Achilles reflexes were absent These was decreased sensaUon to pin, hght touch, and vibration m the distal lower extremtt~es, and decreased pm and hght touch sensation in the m~dhne abdomen Serum and urine tmmunoelectrophoreses were normal Electrodmgnostlc studies revealed an axonal polyneuropathy Sural nerve biopsy was negatwe for amylo~d by Congo red staining and by electron microscopy Sensory and motor deficits progressed and he died suddenly At autopsy, amyloid deposition was demonstrated m obturator nerve, anterior and posterior nerve roots, and heart
Results
Data from the 6 patients stud~ed are presented in Table 1 . The youngest was 62 years old and 5 were male. All presented with dysesthetic limb pain and numbness. Strength varied from normal to severely impaired, and sensory loss was present an all. Four had monoclonal heavy or light chains in serum or urine. None was known to have amyloidosas at the time of presentation, and none had features of other organ involvement at that time The presence of a painful sensorlmotor neuropathy, often with a monoclonal gammopathy, led to consaderation of amyloid neuropathy in all patients. Sural nerve was the first ttssue evaluated for amyloid in all. The time from onset of symptoms to sural nerve biopsy varied from 5 to 36 months. All biopsies revealed an axonal neuropathy, and none demonstrated amyload.
After the nondiagnostic sural nerve biopsy, amylold was eventually identified in all patients by biopsy of other tissue or at autopsy 1 to 21 months after the initial sural nerve biopsy. Patient 3 was the only one to undergo a second sural nerve baopsy. While the first one was negative for amyloid, the second one, obtained 4 months later, contained very small amounts of amyloid on electron microscopy Patient 3 also was unique m that one other tissue which eventually was found to stain positive for amyloid (ileum) was actually obtained at another institution 2 months prior to the first sural nerve biopsy (13 months after onset of symptoms), but was not stained for amylold at that time. Once we suspected amyloidosis but were unable to demonstrate it on sural nerve biopsy, the ileal tissue previously removed was obtained and stained with Congo red, resulting in a diagnosis of amyloidosis
Discussion
Peripheral neuropathy occurs tn 13-35% of patxents with pnmary amyloidosts, may be the presenting symptom of the disease, and may be present for months to years before the diagnosis of amyloldosis is estabhshed (Kyle and Bayrd 1975; Kyle and Greipp 1983; Duston et al. 1989) . Our patients possessed clinical features consistent with amyloid polyneuropathy, and some had monoclonal gammopathles. In such patients, a sural nerve biopsy frequently is performed to look for amyloid deposits
The yield of sural nerve biopsy in patients wtth primary amyloxdosts and peripheral neuropathy ts said to be high. One small series (14 patients) cited a yield of 86% (Kyle and Dyck 1993) . A figure of over 90% has also been cited (Kelly 1985) . Review of other data suggests that the yield may even approach 100% (Kelly et al. 1979; Kyle and Gretpp t983, Janssen et al, 1986) . However, such data are derived from small numbers of patients.
Our yield, while also based on a small number ol patients, is strikingly lower. One factor which may account for this is the timmg of the biopsy relattve to the pattern of amylold deposition within the peripheral nervous system. Proximal portions of the pertpheral nervous system are thought to be involved first, followed by breakdown of the blood-nerve barrier and distal amyloid deposition (De Navasquez and Treble 1938; Verghese et al. 1983 , Hanyu et al. 1989 Sobue et al. 1990; Antoine et al. 1991) . Thus, a patient studied early in the course of amyloidosls may show amyloid deposition only in the proramal pertpheral nervous system. A study later tn the dlness may demonstrate amyloid more distally. Such a pattern of amyloid deposition would explain not only our initial nondmgnostic sural nerve biopsy results, but also the presence ot amyloid in the contralateral sural nerve ot patient 3 several months later and the presence of amyloid in proximal nerve of two of our patients at autopsy. The high yield of sural nerve biopsies previously reported in amyloidosis (Kelly et al 1979; Greipp 1983, Janssen et al. 1986; Kyle and Dyck 1993) may have resulted from a longer duration of peripheral nervous system involvement prior to the time of nerve btops~, although such data cannot be extracted from those reports. The durataon of symptoms in our patients at the time of sural nerve biopsy varied from 5 to 3t~ months, which we believe as representative of the tame a sural nerve biopsy usually would be obtained in such patients.
Technical factors must be considered when comparing our low yield of sural nerve biopsy to the higher values prevaously published. Techniques for evaluating sural nerve btopsies vary from institution to mstttution. Because this was a retrospective study, control for biopsy technique and specimen handling was not possible Arnyloid deposition within a nerve may be patchy, and possibly our yield could have been Increased by the use of very large numbers of sections per nerve or staining for both Congo red and crystal violet. However, this is often not practical in the usual clinical setting, and there is no data to indicate how helpful this might be We believe that our protocol for the processing and study of sural nerve biopsies, resulting m the review of cross and longitudinal Congo red or crystal wolet sections as well as multiple sections for electron microscopy, reflects the type of evaluation performed routinely in large institutions, so that our figures are of interest to clinicians and neuropatholog~sts revolved In the management of such patients A prospective study comparing techniques such as ours to other means of processing sural nerve biopsies would be helpful to address this issue.
Although our series is small, these cases suggest the need for persistence in diagnostic workup if amyloldosis is strongly suspected as the cause of peripheral neuropathy, since the yield of routinely processed sural nerve biopsies in the diagnosis of amyloidosis may be lower than previously believed When patients, particularly older males, present with a painful neuropathy and a monoclonal protein in the serum or urine, the sural nerve biopsy may show only nerve fiber loss. In such cases, biopsy of additional tissue or eventually of the contralateral sural nerve may lead to an accurate diagnosis_
